ACQUIRED · 2022
Who Acquired Intricon Corporation?
Altaris Capital Partners · $236.0M· 16.8× EBITDA
The acquisition
Intricon Corporation was acquired by Altaris Capital Partners in 2022 for $236.0M. The deal was priced at 16.8× EBITDA / 1.60× revenue.
Intricon Corporation at time of acquisition
Revenue
$144.0M
EBITDA
$14.0M
Deal value
$236.0M
EV / EBITDA
16.8×
Other acquisitions by Altaris Capital Partners
Recent transactions by the same buyer — useful for understanding their playbook and what they typically pay.
- Analogic Corporation · 2018 · $937.0M · 13.8× EBITDA
Similar medical devices acquisitions
- Owen Mumford Holdings · acquired by Embecta in 2026 · $201.0M
- Acera Surgical · acquired by Solventum in 2025 · $725.0M
- Alydia Health (Organon JADA System) · acquired by Laborie Medical Technologies in 2025 · $440.0M
- B Medical Systems (Azenta) · acquired by THELEMA S.A. R.L. in 2025 · $63.0M
- BIOTRONIK Vascular Intervention Business · acquired by Teleflex, Inc. in 2025 · $875.9M
Run a valuation for a similar medical devices business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the medical devices calculator →More on medical devices valuations
- Medical Devices valuation calculator· head-term variant
- Medical Devices median multiples· real-deal benchmarks
- How to value a medical devices· long-form guide
Sourced from SEC Fairness Opinion. Primary source. Full deal page.
Citation: ExitValue.ai. (2022). Intricon Corporation acquired by Altaris Capital Partners. https://exitvalue.ai/acquired/intricon-corporation